Viropharma Inc (VPHM) Inventory Turnover Ratio, from third quarter 2013 to third quarter 2012, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Viropharma Inc  (VPHM)
 

Viropharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2013, Viropharma Inc's inventory turnover ratio sequentially decreased to 1.38 in the third quarter 2013, unsurprisingly, as the Viropharma Inc markets continue to deteriorate, and VPHM's faces growing challenges to bring down its inventories. Viropharma Inc's average inventory processing period in the Sep 30 2013 quarter, has increased to 264 days, from 240 days, in the Jun 30 2013 quarter.

Within Healthcare sector 137 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2013, to 694, from total ranking in the second quarter 2013 at 842.

VPHM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Viropharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VPHM Inventory Turnover Ratio (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Inventory Growth 82.47 % 113.79 % 29.47 % 6.74 % -14.78 %
Y / Y Cost of Sales Growth 27.5 % 13.9 % -6.92 % 33.37 % 1.14 %
Inventory Turnover Ratio (TTM) 1.38 1.52 1.76 1.94 1.85
VPHM's Total Ranking # 694 # 842 # 0 # 0 #
Average inventory processing period 265 241 207 188 197
Seq. Inventory Growth 13.99 % 19.65 % 14.02 % 17.34 % 33.55 %
Seq. Cost of Sales Growth -2.41 % -5.7 % 11.3 % 24.48 % -12.82 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 138
Overall Market # 694

Inventory Turnover Ratio Statistics
High Average Low
2.2 2.01 1.82
(Jun 30 2013)   (Sep 30 2013)



VPHM Company Profile >> Back to VPHM Efficiency Comparisons >> Compare VPHM Inventory Turnover Ratio to its Competitors

Financial Statements
Viropharma Inc's Inventories $ 100 Millions Visit VPHM's Balance sheet
Viropharma Inc's Cost of Revenues TTM $ 112 Millions Visit VPHM's Income Statement
What are VPHM's Sales? Visit VPHM's Sales by Segment

Other Inventory Turnover Ratios
Viropharma Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VPHM's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VPHM's Competitors
Inventory Turnover Ratio for VPHM's Suppliers
Inventory Turnover Ratio for VPHM's Customers

You may also want to know
VPHM's Sales Growth Rates VPHM's Pe Price to earnings ratio VPHM's Receivables Turnover Ratio VPHM's Stock Quote
VPHM's Net Income Growth Rates VPHM's Ps Price to Sales ratio VPHM's Sales per Employee VPHM's Asset Turnover Ratio
VPHM's Net Margin VPHM's Pb Price to Book ratio VPHM's Financial Strength Ratios VPHM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2013 Inventories at quarter ending Sep 30 2013
Biolase Inc   3.06 $ 36.195  Millions$ 12  Millions
Horizon Therapeutics Public Limited Company  3.05 $ 17.008  Millions$ 6  Millions
United Therapeutics Corporation  3.04 $ 130.014  Millions$ 43  Millions
Orasure Technologies Inc  2.99 $ 37.604  Millions$ 13  Millions
Merit Medical Systems Inc  2.97 $ 244.793  Millions$ 82  Millions
Dynatronics Corporation  2.96 $ 18.431  Millions$ 6  Millions
Lannett Company Inc  2.95 $ 96.276  Millions$ 33  Millions
Avid Bioservices Inc   2.94 $ 13.733  Millions$ 5  Millions
Synthorx, Inc.  2.93 $ 152.108  Millions$ 52  Millions
Johnson and Johnson  2.88 $ 22,390.000  Millions$ 7,783  Millions
Angiodynamics Inc   2.85 $ 170.187  Millions$ 60  Millions
Allergan plc  2.82 $ 780.400  Millions$ 277  Millions
Medicines Co  2.82 $ 238.674  Millions$ 85  Millions
Becton Dickinson And Company  2.79 $ 3,882.992  Millions$ 1,391  Millions
Atrion Corporation  2.71 $ 67.512  Millions$ 25  Millions
Heska Corporation  2.71 $ 37.608  Millions$ 14  Millions
Yunhong Green Cti Ltd   2.68 $ 41.451  Millions$ 15  Millions
Electromed Inc   2.63 $ 4.507  Millions$ 2  Millions
Nature s Sunshine Products inc   2.61 $ 110.895  Millions$ 42  Millions
Bristol myers Squibb Company  2.57 $ 4,421.000  Millions$ 1,718  Millions
Neogen Corporation  2.57 $ 124.807  Millions$ 49  Millions
Boston Scientific Corporation  2.54 $ 2,201.000  Millions$ 868  Millions
Haemonetics Corporation  2.53 $ 485.083  Millions$ 191  Millions
Teleflex Incorporated  2.51 $ 846.137  Millions$ 338  Millions
Akorn Inc  2.50 $ 137.373  Millions$ 55  Millions
Standard Biotools Inc   2.50 $ 18.608  Millions$ 7  Millions
Ds Healthcare Group, Inc.  2.48 $ 7.827  Millions$ 3  Millions
Thermogenesis Holdings Inc   2.47 $ 11.355  Millions$ 5  Millions
Merck and Co Inc   2.46 $ 16,507.000  Millions$ 6,704  Millions
St Jude Medical Inc  2.46 $ 1,563.000  Millions$ 636  Millions

Date modified: 2026-06-22T16:30:06+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.